Principia Biopharma Inc Net Income per Employee (PRNB), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Principia Biopharma Inc   (NASDAQ: PRNB)
 

Principia Biopharma Inc Net Income per Employee

PRNB's Quarterly Results, Trends, Rankings, Statistics
Principia Biopharma Inc recorded a cumulative net loss of $-15 million during 12 month ending in the second quarter 2020.
The Healthcare sector has seen Principia Biopharma Inc achieved the highest income per employee. While income per employee remained unchanged compared to the previous quarter at no. .


What is Income per Employee Ratio?






PRNB Net Income per Employee (Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
Y / Y Net Income Change 51.93 % - 207.86 % - 295.94 %
Net Income per Employee (TTM) $ -151,170 -188,120 - -194,910 94,880
PRNB's Total Ranking # # # 2804 # 3679 # 740
Seq. Net Income Change - - - - -


PRNB Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Net Income per Employee Statistics
High Average Low
$ 94,880 $ -8,300 $ -194,910
(Jun 30 2019)   (Sep 30 2019)







Companies with similar Income per Employee for 12 month ending Jun 30 2020, within Healthcare Sector Income per Employee Income 12 month ending Jun 30 2020Number of Employees Jun 30 2020


Date modified: 2026-09-26T07:34:42+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.